SOURCE: Telzuit Medical Technologies, Inc.

April 16, 2007 11:35 ET

Telzuit Medical Technologies: Technology Update

ORLANDO, FL -- (MARKET WIRE) -- April 16, 2007 --

--  Successful migration to Windows Mobile 5.0
--  Palm Treo issues resolved
--  Windows XP laptop version in final stages of development
--  FTP of Palm O/S  devices to the Telzuit server is working
--  Human testing of all versions is ongoing
    
Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced that it has been successful in running its STATPATCH Holter Monitor software on various Windows-Mobile devices. The Company is now testing these devices with the "STATPATCH" on human test subjects to ensure that it works for a 24-hour period and receives the data from the patch correctly and consistently.

Palm has created a fix to the problems with the Palm O/S. We are now testing the Palm Treo 680 and Palm Treo 750 (Windows Mobile 5.0 version) with healthy human subjects.

Telzuit, utilizing its outsource computer consultants, CyberTV, is in the final stages of development of its Windows XP laptop version which will be utilized in the nursing home, home health care and emergency medical environment.

The Company has been able to resolve its problems in sending data, using the Palm O/S, to its server in able to provide immediate turnaround of a Holter report utilizing the Phillips Zymed software. Server testing with Windows Mobile will begin in the near future.

Testing on healthy human subjects is ongoing. Testing is expected to take approximately 30 days. If the results of testing are positive, the Company would hope to release the laptop version in May and the PDA version in June.

About Telzuit Medical Technologies, Inc.

Telzuit Medical technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter Monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http://www.telzuit.com.

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:

    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc
    407-354-1222